Interleukin 27 (IL-27), a member of the IL-12 family, is important for T cell differentiation; however, little is known about its effect on dendritic cells (DCs). IL-27 can activate multiple signaling cascades, including the JAK/STAT pathway, and depending on the setting it can both promote and antagonize inflammatory responses. An anti-inflammatory function of IL-27 has been reported in several autoimmune diseases; however, in type 1 diabetes (T1D), an autoimmune disease where autoreactive cytotoxic T cells attack insulin-producing beta cells, IL-27 has been shown to have a dual role and contradictory effects. Here, we show impaired IL-27 signaling in a large cohort of T1D patients (n = 51) compared to age- and gender-matched healthy donors. Increased expression of the IL-27 receptor subunit IL-27Ralpha mRNA in purified myeloid DCs (mDCs), detected by gene expression microarrays was mirrored by enhanced signal transduction in T1D mDCs in response to IL-27 stimulation. Higher STAT phosphorylation in T1D patients was also accompanied by elevated expression of the inhibitory molecules PD-L1, PD-L2 and PD-1, which may suggest not only immunomodulatory mechanisms of IL-27 in T1D but also a compensatory effort of T1D dendritic cells against the ongoing inflammation.

Department of Immunology 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Internal Medicine 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Department of Pediatrics 2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic

Sotio A S Prague Czech Republic

Zobrazit více v PubMed

He J-S, et al. Role of immune dysfunction in pathogenesis of type 1 diabetes mellitus in children. Asian Pac. J. Trop. Med. 2014;7:823–826. doi: 10.1016/S1995-7645(14)60144-9. PubMed DOI

CAVALLO MG, et al. Cytokines in sera from insulin-dependent diabetic patients at diagnosis. Clin. Exp. Immunol. 2008;86:256–259. doi: 10.1111/j.1365-2249.1991.tb05806.x. PubMed DOI PMC

Alnek K, et al. Increased Blood Levels of Growth Factors, Proinflammatory Cytokines, and Th17 Cytokines in Patients with Newly Diagnosed Type 1 Diabetes. PLoS One. 2015;10:e0142976. doi: 10.1371/journal.pone.0142976. PubMed DOI PMC

Devergne O, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J. Virol. 1996;70:1143–53. doi: 10.1128/JVI.70.2.1143-1153.1996. PubMed DOI PMC

Pflanz S, et al. IL-27, a Heterodimeric Cytokine Composed of EBI3 and p28 Protein, Induces Proliferation of Naive CD4+ T Cells. Immunity. 2002;16:779–790. doi: 10.1016/S1074-7613(02)00324-2. PubMed DOI

Takeda A, et al. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 2003;170:4886–90. doi: 10.4049/jimmunol.170.10.4886. PubMed DOI

Awasthi A, et al. A dominant function for interleukin 27 in generating interleukin 10–producing anti-inflammatory T cells. Nat. Immunol. 2007;8:1380–1389. doi: 10.1038/ni1541. PubMed DOI

Murugaiyan G, et al. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J. Immunol. 2009;183:2435–43. doi: 10.4049/jimmunol.0900568. PubMed DOI PMC

Stumhofer JS, et al. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system. Nat. Immunol. 2006;7:937–945. doi: 10.1038/ni1376. PubMed DOI

Pflanz S, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J. Immunol. 2004;172:2225–31. doi: 10.4049/jimmunol.172.4.2225. PubMed DOI

Dietrich C, Candon S, Ruemmele FM, Devergne O. A Soluble Form of IL-27R Is a Natural IL-27 Antagonist. J. Immunol. 2014;192:5382–5389. doi: 10.4049/jimmunol.1303435. PubMed DOI

Fitzgerald DC, et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 2007;179:3268–75. doi: 10.4049/jimmunol.179.5.3268. PubMed DOI

Fitzgerald DC, et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27–stimulated T cells. Nat. Immunol. 2007;8:1372–1379. doi: 10.1038/ni1540. PubMed DOI

Mascanfroni ID, et al. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat. Immunol. 2013;14:1054–1063. doi: 10.1038/ni.2695. PubMed DOI PMC

Meka RR, Venkatesha SH, Dudics S, Acharya B, Moudgil KD. IL-27-induced modulation of autoimmunity and its therapeutic potential. Autoimmun. Rev. 2015;14:1131–1141. doi: 10.1016/j.autrev.2015.08.001. PubMed DOI PMC

Wang R, et al. The pathogenic role of interleukin-27 in autoimmune diabetes. Cell. Mol. Life Sci. 2008;65:3851–3860. doi: 10.1007/s00018-008-8540-1. PubMed DOI PMC

Fujimoto H, et al. IL-27 Inhibits Hyperglycemia and Pancreatic Islet Inflammation Induced by Streptozotocin in Mice. Am. J. Pathol. 2011;179:2327–2336. doi: 10.1016/j.ajpath.2011.08.001. PubMed DOI PMC

Reddy MVPL, et al. Association between type 1 diabetes and GWAS SNPs in the southeast US Caucasian population. Genes Immun. 2011;12:208–12. doi: 10.1038/gene.2010.70. PubMed DOI PMC

Santos AS, et al. Lack of association between IL27 gene variants and type 1 diabetes susceptibility. Cytokine. 2013;61:349–352. doi: 10.1016/j.cyto.2012.12.003. PubMed DOI

Ejtehadifar, M. et al. IL-27: Friend or Foe in the Autoimmune Diseases. Curr. Immunol. Rev. 13 (2018).

Stechova, K. et al. Case report: Type 1 diabetes in monozygotic quadruplets. Eur. J. Hum. Genet. 20 (2012). PubMed PMC

Furuzawa Carballeda J, Fonseca Camarillo G, Yamamoto-Furusho JK. Interleukin 27 is up-regulated in patients with active inflammatory bowel disease. Immunol. Res. 2016;64:901–907. doi: 10.1007/s12026-016-8804-z. PubMed DOI

Melillo JA, et al. Dendritic Cell (DC)-Specific Targeting Reveals Stat3 as a Negative Regulator of DC Function. J. Immunol. 2010;184:2638–2645. doi: 10.4049/jimmunol.0902960. PubMed DOI PMC

DeLong JH, et al. IL-27 and TCR Stimulation Promote T Cell Expression of Multiple Inhibitory Receptors. ImmunoHorizons. 2019;3:13–25. doi: 10.4049/immunohorizons.1800083. PubMed DOI PMC

Hirahara K, et al. Interleukin-27 Priming of T Cells Controls IL-17 Production In trans via Induction of the Ligand PD-L1. Immunity. 2012;36:1017–1030. doi: 10.1016/j.immuni.2012.03.024. PubMed DOI PMC

Carbotti G, et al. IL-27 induces the expression of IDO and PD-L1 in human cancer cells. Oncotarget. 2015;6:43267–80. doi: 10.18632/oncotarget.6530. PubMed DOI PMC

Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 2013;13:227–242. doi: 10.1038/nri3405. PubMed DOI PMC

Guleria I, et al. Mechanisms of PDL1-mediated regulation of autoimmune diabetes. Clin. Immunol. 2007;125:16–25. doi: 10.1016/j.clim.2007.05.013. PubMed DOI

Wang J, et al. Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes. Proc. Natl. Acad. Sci. 2005;102:11823–11828. doi: 10.1073/pnas.0505497102. PubMed DOI PMC

Yadav D, Hill N, Yagita H, Azuma M, Sarvetnick N. Altered availability of PD-1/PD ligands is associated with the failure to control autoimmunity in NOD mice. Cell. Immunol. 2009;258:161–171. doi: 10.1016/j.cellimm.2009.04.006. PubMed DOI

Kadri N, et al. CD4+ Type II NKT Cells Mediate ICOS and Programmed Death-1–Dependent Regulation of Type 1 Diabetes. J. Immunol. 2012;188:3138–3149. doi: 10.4049/jimmunol.1101390. PubMed DOI

Nguyen, Q. T. et al. IL-27 targets Foxp3+ Tregs to mediate antiinflammatory functions during experimental allergic airway inflammation. JCI Insight4 (2019). PubMed PMC

Park Y-J, et al. IL-27 confers a protumorigenic activity of regulatory T cells via CD39. Proc. Natl. Acad. Sci. USA. 2019;116:3106–3111. doi: 10.1073/pnas.1810254116. PubMed DOI PMC

Bin Dhuban K, Bartolucci S, d’Hennezel E, Piccirillo CA. Signaling Through gp130 Compromises Suppressive Function in Human FOXP3+ Regulatory T Cells. Front. Immunol. 2019;10:1532. doi: 10.3389/fimmu.2019.01532. PubMed DOI PMC

Zentsova I, et al. Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients. J. Autoimmun. 2019 doi: 10.1016/j.jaut.2019.06.005. PubMed DOI